Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 40
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 15
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Paul J. Harrison, David M. Bannerman
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3568-3572
Open Access | Times Cited: 23
Molecular mechanism of ligand gating and opening of NMDA receptor
Tsung‐Han Chou, Max Epstein, Russell G. Fritzemeier, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 209-217
Closed Access | Times Cited: 11
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6
Neurobiological mechanisms in the kynurenine pathway and major depressive disorder
Amanda Gollo Bertollo, Maiqueli Eduarda Dama Mingoti, Zuleide Maria Ignácio
Reviews in the Neurosciences (2024)
Closed Access | Times Cited: 6
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Ahmad Zolghadriha, Afagh Anjomshoaa, Mohammad Jamshidi, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Novel mechanisms of Anshen Dingzhi prescription against PTSD: Inhibiting DCC to modulate synaptic function and inflammatory responses
Jiamin Hu, Haipeng Li, Xuncui Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118425-118425
Closed Access | Times Cited: 5
Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection
Jorge Y. Magdaleno Roman, Christian Chapa González
Neuroprotection/Neuroprotection (Chichester, England. Print) (2024) Vol. 2, Iss. 2, pp. 137-150
Open Access | Times Cited: 5
Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms
Dabing Li, Qiangwen Pan, Yewei Xiao, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
Amany Digal Ladagu, Funmilayo Eniola Olopade, Adeboye Adejare, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1535-1535
Open Access | Times Cited: 13
Context is key: glucocorticoid receptor and corticosteroid therapeutics in outcomes after traumatic brain injury
Morgan Taylor, Olga N. Kokiko‐Cochran
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Characterization of Mice Carrying a Neurodevelopmental Disease-Associated GluN2B(L825V) Variant
Miriam Candelas, Viktor Kuchtiak, Agnieszka Kubik‐Zahorodna, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 31, pp. e2291232024-e2291232024
Closed Access | Times Cited: 4
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease
Aaron Koenig, Michael Lewis, Jeff Wald, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 4
Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
Sumedha Gupta, Abhishek Gupta, Sidharth Mehan, et al.
Neuroscience (2025)
Closed Access
Novel Piperazine Derivatives as Selective Antagonists of GluN2B-Containing NMDARs under Acidic pH Conditions
Yinlong Li, Steven H. Liang
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 354-355
Closed Access
Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity
Fabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor
John E. Donello, Roger S. McIntyre, Donald B. Pickel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 157-157
Open Access
A genetically encoded secreted toxin potentiates synaptic NMDA receptors in hippocampal neurons and confers neuroprotection
Ido Carmi, Shaden Zoabi, Asaf M Bittan, et al.
PNAS Nexus (2025) Vol. 4, Iss. 2
Open Access
Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor
Hyunook Kang, Max Epstein, Tue G. Banke, et al.
Neuron (2025)
Closed Access
New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d-aspartate Receptor Antagonists
Marco Banzato, Alberto Furlan, Patrizia Locatelli, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Preliminary pharmacokinetics and in vivo studies indicate analgesic and stress mitigation effects of a novel NMDA receptor modulator
Blaise M. Costa, De'Yana Hines, Nakia Phillip, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103401-103401
Closed Access
Pleiotropic neurotransmitters: neurotransmitter-receptor crosstalk regulates excitation-inhibition balance in social brain functions and pathologies
Anping Chai
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology
Michal Korinek, M C Serra, Fes Abdel Rahman, et al.
Physiological Research (2024), Iss. Suppl 1, pp. S413-S434
Open Access | Times Cited: 3
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
Roger S. McIntyre, Rakesh Jain
CNS Drugs (2024) Vol. 38, Iss. 11, pp. 869-890
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top